GenZum Life Sciences is a multinational privately held company. Founded in 2008, Genzum had humble beginnings as a incubation concept, for earlier ANDA development projects. Realizing the dynamics of increasing cost pressures, industry specific challenges and the gap between traditional drug development models and those yet to be utilized- the founding members of Genzum applied their unique industry understanding, development life cycle expertise and a collective R&D and clinical trial infrastructure; in order to optimized the drug development life cycle and commercial collaboration partnerships.

As a result, GenZum Life Sciences has successfully submitted and is pending FDA approval on a number of first-to-market ANDA opportunities and continues to invest, manage and commercialize a robust pipeline of ANDA and 505(b)2 development projects that are at various stages of development.

Looking ahead, we are committed to growing our development pipeline and product portfolio, investing heavily in internal initiatives, innovative collaborations and strategic partnerships.
Want to be part of our story? Join us at: